News | Artificial Intelligence | April 07, 2020

The agreement is intended to integrate Qure.ai’s proprietary technology for chest x-ray screening and head CT triage in the Nanox.Cloud to improve imaging solutions and increase patient access to medical imaging world-wide

The agreement is intended to integrate Qure.ai’s proprietary technology for chest x-ray screening and head CT triage in the Nanox.Cloud to improve imaging solutions and increase patient access to medical imaging world-wide

April 7, 2020 — -NANO-X IMAGING LTD (Nanox), an innovative medical imaging company, announces its collaboration with Qure.ai, a leading healthcare AI startup, to integrate Qure.ai’s diagnostics solution into Nanox’s planned cloud-based software platform, the Nanox.CLOUD. This partnership follows another agreement with CureMetrix that was announced earlier this year.

Nanox is working to expand the range of medical imaging services it intends to provide to improve the accessibility and affordability of early-detection services. The Nanox.CLOUD is designed to provide an end-to-end medical imaging service, including services such as image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence (AI) systems, billing and reporting.

A head computed tomography (CT) scan is usually a diagnostic test patients undergo at an early stage if they have a head injury or symptoms suggesting stroke. Radiologists in ICUs or ERs might not be immediately available to read a scan or might have many scans pending. Prompt detection of head injury is critical to increase patients’ chances for recovery.

Qure.ai’s solution detects critical abnormalities, such as bleeds, fractures, mass effect and midline shift, localizes them and quantifies their severity. Qure.ai’s solutions are all CE certified, and its head CT product (qER) is the only solution in the industry to detect every critical brain abnormality on a head CT, including five types of intracranial hemorrhages, cranial fractures, infarcts, midline shift and mass effect (for tumor detection).

"We’re gradually onboarding the key players in AI and healthcare that share our vision. Qure.ai is joining our planned imaging platform aimed to decrease diagnostic results turnaround time, increase diagnostic accuracy and help radiologists deal with the rising screening demands and workload,” said Ran Poliakine, founder and CEO of Nanox.

“Our latest partnership with Nanox has the potential to take Qure.ai’s AI-powered diagnostics to a large network of radiologists and clinicians who can benefit from our faster and accurate CT scan interpretation. Our solution that seamlessly integrates with radiologists’ workflow can transform patient care by allowing radiologists to focus on the more critical and urgent patient cases,” explained Prashant Warier, CEO and co-founder of Qure.ai.

For more information: www.nanox.vision

Related Content

News | Artificial Intelligence

May 27, 2022 — PaxeraHealth announced that the University of Pennsylvania has selected its zero-coding authoring ...

Time May 27, 2022
arrow
News | Enterprise Imaging

May 26, 2022 — ScImage, Inc., a leading provider of cloud-centric enterprise imaging, PACS, and image exchange solutions ...

Time May 26, 2022
arrow
News | Artificial Intelligence

May 25, 2022 — A new method that combines imaging information with artificial intelligence (AI) can diagnose ...

Time May 25, 2022
arrow
News | Coronavirus (COVID-19)

May 24, 2022 — A special type of MRI found lung abnormalities in patients who had previously had COVID-19, even those ...

Time May 24, 2022
arrow
News | Lung Imaging

May 23, 2022 — Xoran Technologies announced they have completed Phase 1 for their NHLBI grant for mobile lung CT. Just ...

Time May 23, 2022
arrow
News | Electronic Medical Records (EMR)

May 20, 2022 — DrChrono Inc., an EverHealth solution and essential platform for modern medical practices, announced that ...

Time May 20, 2022
arrow
News | Contrast Media

May 19 2022 — Recent disruptions in a pharmaceutical supply chain have impacted the global availability of GE Healthcare ...

Time May 19, 2022
arrow
News | Breast Imaging

May 18, 2022 — Therapixel, a company leading the use of AI-based software for women’s health, announces it has released ...

Time May 18, 2022
arrow
Feature | Radiology Business | By Merilee Kern, MBA

Numerous indicators make clear that the next five years will usher in extreme transformation for a multitude of ...

Time May 18, 2022
arrow
News | Digital Pathology

May 17, 2022 — Proscia, a leader in digital and computational pathology solutions, has introduced an automated quality ...

Time May 17, 2022
arrow
Subscribe Now